Could a daily ear zap ease your back pain?
NCT ID NCT05639270
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small pilot study tested whether using a special ear electrode for 30 minutes each day could help people with long-lasting low back pain. The device gently stimulates the vagus nerve, which is known to affect pain and mood. Thirty adults with chronic low back pain that hadn't improved with other treatments used the device and had their pain and disability measured after one month.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- auricular electrode (vagal nerve stimulation device)
- What this could lead to
- If it works, this could point toward a simple, non-drug daily treatment to reduce chronic low back pain and improve daily function.
- What could go wrong
- This is a very small pilot study with only 30 people and no comparison group, so results may not be reliable or apply to everyone. The device may cause discomfort or not help pain at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Mar 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Low back pain with a VAS greater than or equal to 40 that has been ongoing for more than 3 months * Failed or insufficiently relieved by private physiotherapy * Failed or insufficiently relieved or intolerant of level II analgesics * No change in therapy envisaged within one month. Exclusion Criteria: * Non-common low back pain will not be accepted (presence of red flags). * Auricular canal not adapted to the stimulation device. * Use of another type of electrical device (pacemaker or TENS). * History of vagotomy. * Heart rhythm disorder. * Presence of a cochlear implant on the stimulation side * Pregnancy in progress or planned during the study period * Adult protected by law or patient under guardianship or curator * Person unable to give consent. * Participation in other ongoing biomedical research * Absence of express informed consent after a reflection period * Not being affiliated to a French social security system or being a beneficiary of such a system
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Low back pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Montpellier
Montpellier, France, 34295, France
-
CHU Nîmes - Le Grau du Roi
Nîmes, 30240, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pilates takes on standard physical therapy in battle against Work-Related back pain
- Radiofrequency device tested as Add-On for stubborn back pain
- Back muscles hold clues for treating recurrent low back pain
- Skip the GP? physiotherapy first for back pain put to the test
- Can yoga ease back pain when recovery looks unlikely?
- Can a second injection target the source of stubborn back pain?